Use of multikinase inhibitors/lenvatinib in singular thyroid cancer scenarios

Zafon Llopis, Carles; Castelo, Beatriz

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Zafon Llopis, Carles
dc.contributor.author	Castelo, Beatriz
dc.date.accessioned	2022-11-16T12:50:06Z
dc.date.available	2022-11-16T12:50:06Z
dc.date.issued	2022-10
dc.identifier.citation	Zafón C, Castelo B. Use of multikinase inhibitors/lenvatinib in singular thyroid cancer scenarios. Cancer Med. 2022 Oct;11(Suppl. 1):3–4.
dc.identifier.issn	2045-7634
dc.identifier.uri	https://hdl.handle.net/11351/8486
dc.description	Lenvatinib; Càncer de tiroide
dc.description.sponsorship	The authors received honoraria payment from Eisai Farmacéutica SA in line with ICMJE guidelines.
dc.language.iso	eng
dc.publisher	Wiley
dc.relation.ispartofseries	Cancer Medicine;11(Suppl. 1)
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Tiroide - Càncer - Tractament
dc.subject	Medicaments antineoplàstics - Ús terapèutic
dc.subject	Medicaments antineoplàstics - Efectes secundaris
dc.subject.mesh	Thyroid Neoplasms
dc.subject.mesh	/drug therapy
dc.subject.mesh	Antineoplastic Agents
dc.subject.mesh	/adverse effects
dc.title	Use of multikinase inhibitors/lenvatinib in singular thyroid cancer scenarios
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1002/cam4.5154
dc.subject.decs	neoplasias de la tiroides
dc.subject.decs	/farmacoterapia
dc.subject.decs	antineoplásicos
dc.subject.decs	/efectos adversos
dc.relation.publishversion	https://doi.org/10.1002/cam4.5154
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Zafón C] Servei d’Endocrinologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Castelo B] Department of Medical Oncology, University Hospital La Paz, Madrid, Spain
dc.identifier.pmid	36202604
dc.identifier.wos	000864415600002
dc.rights.accessrights	info:eu-repo/semantics/openAccess